Low 25-hydroxyvitamin D serum levels correlate with the presence of extra-hepatic manifestations in chronic hepatitis C virus infection

Rheumatology (United Kingdom)

Volumn 51, Issue 11, 2012, Pages 2083-2090

  Terrier, Benjamin ^a,b   Jehan, Frédéric ^c   Munteanu, Mona ^a   Geri, Guillaume ^a,b   Saadoun, David ^a,b   Sène, Damien ^a   Poynard, Thierry ^a   Souberbielle, Jean Claude ^c   Cacoub, Patrice ^a,b  

^a SORBONNE UNIVERSITÉ   (France)

^b CNRS   (France)

^c UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

25(OH)D; Cryoglobulinaemia; HCV; Vasculitis

Indexed keywords

25 HYDROXYVITAMIN D; COMPLEMENT COMPONENT C4; CRYOGLOBULIN;

ADULT; ARTICLE; BLOOD LEVEL; COHORT ANALYSIS; CONTROLLED STUDY; CRYOGLOBULINEMIA; DISEASE ASSOCIATION; EXTRAHEPATIC DISEASE; FEMALE; HEPATITIS C; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER DISEASE; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; REGULATORY T LYMPHOCYTE; VASCULITIS; VITAMIN D DEFICIENCY;

B-LYMPHOCYTES; COMPLEMENT C4; CRYOGLOBULINEMIA; FEMALE; HEPATITIS C, CHRONIC; HUMANS; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SEASONS; SYSTEMIC VASCULITIS; T-LYMPHOCYTES; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 84867795412     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/kes209     Document Type: Article

References (31)

1. Agnello V, Chung RT, Kaplan LM. A role for hepatitis c virus infection in type ii cryoglobulinemia. N Engl J Med 1992; 327: 1490-5.
2. Sansonno D, Dammacco F. Hepatitis C virus, cryoglobulinaemia, and vasculitis: immune complex relations. Lancet Infect Dis 2005; 5: 227-36.
3. Sansonno D, De Vita S, Iacobelli AR et al. Clonal analysis of intrahepatic B cells from HCV-infected patients with and without mixed cryoglobulinemia. J Immunol 1998; 160: 3594-601.
4. Franzin F, Efremov DG, Pozzato G et al. Clonal B-cell expansions in peripheral blood of HCV-infected patients. Br J Haematol 1995; 90: 548-52.
5. Racanelli V, Sansonno D, Piccoli C et al. Molecular characterization of B cell clonal expansions in the liver of chronically hepatitis C virus-infected patients. J Immunol 2001; 167: 21-9.
6. Vallat L, Benhamou Y, Gutierrez M et al. Clonal B cell populations in the blood and liver of patients with chronic hepatitis C virus infection. Arthritis Rheum 2004; 50: 3668-78.
7. Charles ED, Green RM, Marukian S et al. Clonal expansion of immunoglobulin M+CD27+ B cells in HCV-associated mixed cryoglobulinemia. Blood 2008; 111: 1344-56.
8. Saadoun D, Bieche I, Maisonobe T et al. Involvement of chemokines and type 1 cytokines in the pathogenesis of hepatitis C virus-associated mixed cryoglobulinemia vasculitis neuropathy. Arthritis Rheum 2005; 52: 2917-25.
9. Boyer O, Saadoun D, Abriol J et al. CD4+CD25+ regulatory T-cell deficiency in patients with hepatitis C-mixed cryoglobulinemia vasculitis. Blood 2004; 103: 3428-30.
10. Landau DA, Rosenzwajg M, Saadoun D et al. Correlation of clinical and virologic responses to antiviral treatment and regulatory T cell evolution in patients with hepatitis C virus-induced mixed cryoglobulinemia vasculitis. Arthritis Rheum 2008; 58: 2897-907.
11. Mora JR, Iwata M, von Andrian UH. Vitamin effects on the immune system: vitamins A and D take centre stage. Nat Rev Immunol 2008; 8: 685-98.
12. Jeffery LE, Burke F, Mura M et al. 1,25-Dihydroxyvitamin D3 and IL-2 combine to inhibit T cell production of inflammatory cytokines and promote development of regulatory T cells expressing CTLA-4 and FoxP3. J Immunol 2009; 183: 5458-67.
13. Petta S, Camma C, Scazzone C et al. Low vitamin d serum level is related to severe fibrosis and low responsiveness to interferon-based therapy in genotype 1 chronic hepatitis C. Hepatology 2010; 51: 1158-67.
14. Gorevic PD, Kassab HJ, Levo Y et al. Mixed cryoglobulinemia: clinical aspects and long-term follow-up of 40 patients. Am J Med 1980; 69: 287-308.
15. Jennette JC, Falk RJ. Small-vessel vasculitis. N Engl J Med 1997; 337: 1512-23.
16. Musset L, Diemert MC, Taibi F et al. Characterization of cryoglobulins by immunoblotting. Clin Chem 1992; 38: 798-802.
17. Cacoub P, Lidove O, Maisonobe T et al. Interferon-alpha and ribavirin treatment in patients with hepatitis C virus-related systemic vasculitis. Arthritis Rheum 2002; 46: 3317-26.
18. Imbert-Bismut F, Ratziu V, Pieroni L et al. Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study. Lancet 2001; 357: 1069-75.
19. Jaffe ES. The 2008 WHO classification of lymphomas: implications for clinical practice and translational research. Hematology Am Soc Hematol Educ Program 2009; 523-31.
20. Hollis BW, Kamerud JQ, Selvaag SR, Lorenz JD, Napoli JL. Determination of vitamin D status by radioimmunoassay with an 125I-labeled tracer. Clin Chem 1993; 39: 529-33.
21. Targher G, Bertolini L, Scala L et al. Associations between serum 25-hydroxyvitamin D3 concentrations and liver histology in patients with non-alcoholic fatty liver disease. Nutr Metab Cardiovasc Dis 2007; 17: 517-24.
22. Wolf M, Betancourt J, Chang Y et al. Impact of activated vitamin D and race on survival among hemodialysis patients. J Am Soc Nephrol 2008; 19: 1379-88.
23. Kovesdy CP, Ahmadzadeh S, Anderson JE, Kalantar-Zadeh K. Association of activated vitamin d treatment and mortality in chronic kidney disease. Arch Intern Med 2008; 168: 397-403.
24. Tan X, Li Y, Liu Y. Paricalcitol attenuates renal interstitial fibrosis in obstructive nephropathy. J Am Soc Nephrol 2006; 17: 3382-93.
25. Tan X, Li Y, Liu Y. Therapeutic role and potential mechanisms of active vitamin D in renal interstitial fibrosis. J Steroid Biochem Mol Biol 2007; 103: 491-6.
26. Artaza JN, Norris KC. Vitamin D reduces the expression of collagen and key profibrotic factors by inducing an antifibrotic phenotype in mesenchymal multipotent cells. J Endocrinol 2009; 200: 207-21.
27. Terrier B, Sene D, Saadoun D et al. Serum-free light chain assessment in hepatitis C virus-related lymphoproliferative disorders. Ann Rheum Dis 2009; 68: 89-93.
28. Terrier B, Joly F, Vazquez T et al. Expansion of functionally anergic CD21-/low marginal zone-like B cell clones in hepatitis C virus infection-related autoimmunity. J Immunol 2011; 187: 6550-63.
29. Charles ED, Brunetti C, Marukian S et al. Clonal B cells in patients with hepatitis C virus-associated mixed cryoglobulinemia contain an expanded anergic CD21low B-cell subset. Blood 2011; 117: 5425-37.
30. Michel J, Langstein J, Hofstadter F, Schwarz H. A soluble form of CD137 (ILA/4-1BB), a member of the TNF receptor family, is released by activated lymphocytes and is detectable in sera of patients with rheumatoid arthritis. Eur J Immunol 1998; 28: 290-5.
31. Michel J, Schwarz H. Expression of soluble CD137 correlates with activation-induced cell death of lymphocytes. Cytokine 2000; 12: 742-6.